Immunoassay Market by Technology, Analyzers & Reagents, Applications & End Users - Global Forecast to 2018

News provided by

Research and Markets

10 Feb, 2014, 23:00 GMT

DUBLIN, February 10, 2014 /PRNewswire/ --

Dublin - Research and Markets (http://www.researchandmarkets.com/research/3q7md6/immunoassay) has announced the addition of the "Immunoassay Market by Technology, Analyzers & Reagents, Applications & End Users - Global Forecast to 2018" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


The global market is segmented on the basis of technology, application, product (analyzers and reagents), and end user. The global market, by technology, is further segmented into enzyme, fluorescent, chemiluminescence immunoassay, radioimmunoassay, and others. Enzyme and chemiluminescence immunoassay are two of the largest segments, accounting for a total of -65% of the market share globally in 2012.

By application, this market has segments like oncology, infectious diseases, cardiology, bone and mineral, endocrinology, autoimmunity, toxicology, hematology, neonatal screening, and others. Infectious disease is the largest segment with more than one-third share of the total market. This is attributed to the increasing prevalence of infectious diseases along with continuous product innovations and launches.

The global market is valued around $13.0 billion in 2013 and is expected to grow at a healthy CAGR of 8.1% to reach $19.1 billion by 2018. Expanding use of immunoassay, increasing demand for high-quality healthcare services, and rapidly increasing geriatric population are the major factors driving the global market. New and innovative product launches by the key industry players also boost the market. However, the rising commoditization of certain immunoassay, uncertain regulatory environment, and reduction in the healthcare budget are critical restraints for the growth of the market.

The key market vendors in this arena are Abbott Laboratories (U.S.), Alere, Inc. (U.S.), Danaher Corporation (U.S.), DiaSorin S.P.A. (Italy), Ortho Clinical Diagnostics (U.S.), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), and Sysmex Corporation (Japan). 


Key Topics Covered: 

1 Introduction

2 Executive Summary 

3 Premium Insights

4 Industry Analysis & Market Overview 

5 Immunoassay Market, By Technology 

6 Immunoassay Market, By Products (Analyzers & Reagents) 

7 Immunoassay Market, By Application

8 Global Immunoassay Market, By End-Users 

9 Geographic Analysis

10 Competitive Landscape 

11 Company Profiles


Companies Mentioned:

  • Abbott Laboratories, Inc
  • Alere, Inc
  • Becton, Dickinson And Company
  • Biomérieux
  • DRG International, Inc
  • Danaher Corporation (Beckman Coulter)
  • Diasorin SPA
  • Diasource Immunoassays SA
  • Hologic (Gen-Probe )
  • IBL International GMBH
  • IDS Plc
  • Meridian Life Science, Inc
  • Ortho Clinical Diagnostics (A J&J Company)
  • Qiagen NV
  • Roche Diagnostics Limited
  • Siemens Healthcare
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc (Brahms)


For more information visit http://www.researchandmarkets.com/research/3q7md6/immunoassay


Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets